secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001178913-24-000035
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio receives 180-day Nasdaq extension to June 24, 2024 to meet $1.00 bid price rule
--------------------------------------------------------------------------------

- Nasdaq granted 180-day extension on Dec 27, 2023; new compliance deadline is June 24, 2024.
- Must maintain closing bid price of at least $1.00 for 10 consecutive business days.
- Company may pursue reverse stock split to regain compliance.
- Failure to comply by June 24, 2024 could lead to delisting; trading continues for now.
- Extended period has no immediate effect on listing or trading under symbol ENTX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891324000035/0001178913-24-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891324000035/zk2430720.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer